世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

遺伝子パネル市場:製品・サービス毎、技術毎(アンプリコン、ハイブリダイゼーション・異種交配)、設計毎(プレデザイン、カスタム)、用途毎(がん、先天性疾患、薬理遺伝学)、エンドユーザ毎(病院、研究センタ、医薬品企業) - 2023年までの世界市場予測

Gene Panel Market by Product & Service, Technique (Amplicon, Hybridization), Design (Predesign, Custom), Application (Cancer, Congenital Disease, Pharmacogenetics) & End User (Hospital, Research Center, Pharmaceutical Companies) - Global Forecast to 2023

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2018年5月US$4,950
シングルユーザライセンス
142 124

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の遺伝子パネル市場に関する調査レポートです。

“The global gene panels market projected to grow at a CAGR of 19.2%.”

The global gene panels market is expected to reach USD 2.95 billion by 2023 from USD 1.22 billion in 2018, at a CAGR of 19.2%. This market is experiencing significant growth due increasing prevalence of chronic diseases, growing company initiatives (in terms of strategic partnerships, collaborations, and product launches), and growing adoption of gene panels owing to the benefits they offer. However, issues related to the security of genetic data and accuracy & standardization concerns in diagnostic testing are restricting the growth of this market

“The testing services segment is projected to grow at the highest CAGR during the forecast period.”

Based on product & service, the market is segmented into test kits and testing services. The test services segment is projected to register the highest CAGR during the forecast period. Factors such as the increasing focus of market players on providing efficient gene panel services to researchers and the growing number of government funding programs for genomic research are likely to drive the market for gene panel testing services.

“By application, the cancer risk assessment segment held the largest share of the market during the forecast period.”

Based on applications, the market is segmented into cancer risk assessment, diagnosis of congenital diseases, pharmacogenetics, and other applications. The cancer risk assessment segment held the largest share of the gene panels market in 2018. It is also projected to register the highest growth during the forecast period due to the increasing incidence of cancer and the growing demand for gene panels in research and diagnostics to understand the genetic variability of cancer.

“North America to witness the highest growth during the forecast period.”

In 2018, North America is expected to account for the largest share of the market followed by Europe. North America is also projected to register the highest CAGR during the forecast period. This can be attributed to factors such as the government support for genomics research, presence of leading NGS providers, and growing research on cancer and inherited rare diseases in the region.

The primary interviews conducted for this report can be categorized as follows:

- By Company Type: Tier 1 - 30%; Tier 2 - 42%; Tier 3 - 28%
- By Designation: C-level- 25%; D-level- 45%; Others- 30%
- By Region: North America-48%; Europe-29%; Asia Pacific-19%; Rest of the World-4%

List of companies profiled in the report

- Illumina, Inc. (US)
- Thermo Fisher Scientific (US)
- Agilent Technologies (US)
- QIAGEN (Germany)
- BGI (China)
- Eurofins Scientific (US)
- F. Hoffmann-La Roche AG (Switzerland)
- Integrated DNA Technologies (US)
- GATC Biotech AG (Germany)
- GENEWIZ, Inc. (US)
- Novogene Corporation (China)
- Personalis (US)
- ArcherDx (US).

Research Coverage:

The report provides an overview of the gene panels market. It aims at estimating the market size and future growth potential of this market across different segments such as product & service, technique, design, application, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall gene panels market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.



目次

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKET COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 MARKET STAKEHOLDERS 17

2 RESEARCH METHODOLOGY 18
2.1 SECONDARY DATA 19
2.2 PRIMARY DATA 20
2.3 KEY INDUSTRY INSIGHTS 21
2.4 MARKET SIZE ESTIMATION 21
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.6 ASSUMPTIONS FOR THE STUDY 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 30
4.1 GENE PANELS MARKET OVERVIEW 30
4.2 GENE PANELS MARKET, BY TYPE, 2018-2023 31
4.3 GENE PANELS MARKET, BY END USER, 2018 VS. 2023 (USD BILLION) 31
4.4 GEOGRAPHIC ANALYSIS: GENE PANELS MARKET IN EUROPE, BY APPLICATION 32
4.5 GEOGRAPHICAL SNAPSHOT OF THE GENE PANELS MARKET 33

5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.2 MARKET DYNAMICS 34
5.2.1 DRIVERS 35
5.2.1.1 Increasing prevalence of chronic diseases 35
5.2.1.2 Growing company initiatives 36
5.2.1.3 Benefits of gene panels 36
5.2.2 RESTRAINTS 37
5.2.2.1 Issues related to the security of genetic data 37
5.2.3 OPPORTUNITIES 37
5.2.3.1 Government initiatives in population sequencing 37
5.2.3.2 Growth opportunities in emerging markets 38
5.2.4 CHALLENGES 38
5.2.4.1 Accuracy and standardization concerns in diagnostic testing 38

6 GENE PANELS MARKET, BY PRODUCT & SERVICE 39
6.1 INTRODUCTION 40
6.2 TEST KITS 41
6.3 TESTING SERVICES 41

7 GENE PANELS MARKET, BY TECHNIQUE 43
7.1 INTRODUCTION 44
7.2 AMPLICON-BASED APPROACH 45
7.3 HYBRIDIZATION-BASED APPROACH 46

8 GENE PANELS MARKET, BY DESIGN 47
8.1 INTRODUCTION 48
8.2 PREDESIGNED GENE PANELS 49
8.3 CUSTOMIZED GENE PANELS 50

9 GENE PANELS MARKET, BY APPLICATION 51
9.1 INTRODUCTION 52
9.2 CANCER RISK ASSESSMENT 53
9.2.1 SYNDROME-SPECIFIC GENE PANELS 54
9.2.2 HIGH-PENETRANCE GENE PANELS 55
9.2.3 HIGH AND MODERATE-PENETRANCE GENE PANELS 55
9.2.4 COMPREHENSIVE CANCER RISK PANELS 56
9.3 PHARMACOGENETICS 56
9.4 DIAGNOSIS OF CONGENITAL DISORDERS 57
9.5 OTHER APPLICATIONS 58

10 GENE PANELS MARKET, BY END USER 59
10.1 INTRODUCTION 60
10.2 RESEARCH & ACADEMIC INSTITUTES 61
10.3 HOSPITALS & DIAGNOSTIC LABORATORIES 62
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 63

11 GENE PANELS MARKET, BY REGION 64
11.1 INTRODUCTION 65
11.2 NORTH AMERICA 66
11.2.1 US 70
11.2.2 CANADA 73
11.3 EUROPE 76
11.3.1 GERMANY 80
11.3.2 UK 82
11.3.3 FRANCE 85
11.3.4 REST OF EUROPE (ROE) 87
11.4 ASIA PACIFIC 90
11.5 REST OF THE WORLD (ROW) 94

12 COMPETITIVE LANDSCAPE 98
12.1 OVERVIEW 98
12.2 MARKET SHARE ANALYSIS 99
12.3 COMPETITIVE SITUATION AND TRENDS 100
12.3.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 100
12.3.2 PRODUCT LAUNCHES AND UPGRADES 101
12.3.3 ACQUISITIONS 101
12.3.4 EXPANSIONS 102

13 COMPANY PROFILES 103
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 ILLUMINA, INC. 103
13.2 THERMO FISHER SCIENTIFIC INC. 106
13.3 AGILENT 109
13.4 QIAGEN 112
13.5 EUROFINS SCIENTIFIC SE 115
13.6 BGI 118
13.7 F. HOFFMANN-LA ROCHE AG 120
13.8 INTEGRATED DNA TECHNOLOGIES 122
13.9 GENEWIZ, INC. 124
13.10 NOVOGENE CORPORATION 126
13.11 PERSONALIS, INC. 128
13.12 GATC BIOTECH AG 129
13.13 ARCHERDX 130

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14 APPENDIX 132
14.1 INSIGHTS OF INDUSTRY EXPERTS 132
14.2 DISCUSSION GUIDE 133
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 136
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 138
14.5 AVAILABLE CUSTOMIZATIONS 139
14.6 RELATED REPORTS 139
14.7 AUTHOR DETAILS 140

 

LIST OF TABLES

TABLE 1 GENE PANELS MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 40
TABLE 2 TEST KITS MARKET, BY REGION, 2018-2023 (USD MILLION) 41
TABLE 3 TESTING SERVICES MARKET, BY REGION, 2018-2023 (USD MILLION) 42
TABLE 4 GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION) 44
TABLE 5 GENE PANELS MARKET FOR AMPLICON-BASED APPROACH, BY REGION,
2016-2023 (USD MILLION) 45
TABLE 6 GENE PANELS MARKET FOR HYBRIDIZATION-BASED APPROACH,
BY REGION, 2016-2023 (USD MILLION) 46
TABLE 7 GENE PANELS MARKET, BY DESIGN, 2018-2022 (USD MILLION) 48
TABLE 8 PREDESIGNED GENE PANELS MARKET, BY REGION, 2018-2023 (USD MILLION) 49
TABLE 9 CUSTOMIZED GENE PANELS MARKET, BY REGION, 2018-2023 (USD MILLION) 50
TABLE 10 GENE PANELS MARKET, BY APPLICATION, 2018-2022 (USD MILLION) 52
TABLE 11 GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY REGION,
2018-2022 (USD MILLION) 53
TABLE 12 GENE PANELS MARKET FOR CANCER RISK ASSESSMENT, BY TYPE,
2018-2022 (USD MILLION) 54
TABLE 13 SYNDROME-SPECIFIC GENE PANELS MARKET, BY REGION,
2018-2022 (USD MILLION) 54
TABLE 14 HIGH-PENETRANCE GENE PANELS MARKET, BY REGION,
2018-2022 (USD MILLION) 55
TABLE 15 HIGH AND MODERATE-PENETRANCE GENE PANELS MARKET,
BY REGION, 2018-2022 (USD MILLION) 55
TABLE 16 COMPREHENSIVE CANCER RISK GENE PANELS MARKET,
BY REGION, 2018-2022 (USD MILLION) 56
TABLE 17 GENE PANELS MARKET FOR PHARMACOGENETICS, BY REGION,
2018-2022 (USD MILLION) 57
TABLE 18 GENE PANELS MARKET FOR THE DIAGNOSIS OF CONGENITAL DISORDERS,
BY REGION, 2018-2022 (USD MILLION) 57
TABLE 19 GENE PANELS MARKET FOR OTHER APPLICATIONS, BY REGION,
2018-2022 (USD MILLION) 58
TABLE 20 GENE PANELS MARKET, BY END USER, 2016-2023 (USD MILLION) 60
TABLE 21 GENE PANELS MARKET FOR RESEARCH & ACADEMIC INSTITUTES,
BY REGION, 2016-2023 (USD MILLION) 61
TABLE 22 GENE PANELS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES,
BY REGION, 2016-2023 (USD MILLION) 62
TABLE 23 GENE PANELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2023 (USD MILLION) 63
TABLE 24 GENE PANELS MARKET, BY REGION, 2016-2023 (USD MILLION) 65
TABLE 25 NORTH AMERICA: GENE PANELS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 68
TABLE 26 NORTH AMERICA: GENE PANELS MARKET, BY PRODUCT & SERVICE,
2016-2023 (USD MILLION) 68
TABLE 27 NORTH AMERICA: GENE PANELS MARKET, BY TECHNIQUE,
2016-2023 (USD MILLION) 68
TABLE 28 NORTH AMERICA: GENE PANELS MARKET, BY DESIGN, 2016-2023 (USD MILLION) 69
TABLE 29 NORTH AMERICA: GENE PANELS MARKET, BY APPLICATION,
2016-2023 (USD MILLION) 69
TABLE 30 NORTH AMERICA: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT,
BY TYPE, 2016-2023 (USD MILLION) 69
TABLE 31 NORTH AMERICA: GENE PANELS MARKET, BY END USER,
2016-2023 (USD MILLION) 70
TABLE 32 US: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION) 71
TABLE 33 US: GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION) 71
TABLE 34 US: GENE PANELS MARKET, BY DESIGN, 2016-2023 (USD MILLION) 71
TABLE 35 US: GENE PANELS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 72
TABLE 36 US: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT,
BY TYPE, 2016-2023 (USD MILLION) 72
TABLE 37 US: GENE PANELS MARKET, BY END USER, 2016-2023 (USD MILLION) 72
TABLE 38 CANADA: GENE PANELS MARKET, BY PRODUCT & SERVICE,
2016-2023 (USD MILLION) 73
TABLE 39 CANADA: GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION) 74
TABLE 40 CANADA: GENE PANELS MARKET, BY DESIGN, 2016-2023 (USD MILLION) 74
TABLE 41 CANADA: GENE PANELS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 74
TABLE 42 CANADA: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT,
BY TYPE, 2016-2023 (USD MILLION) 75
TABLE 43 CANADA: GENE PANELS MARKET, BY END USER, 2016-2023 (USD MILLION) 75
TABLE 44 EUROPE: GENE PANELS MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 78
TABLE 45 EUROPE: GENE PANELS MARKET, BY PRODUCT & SERVICE,
2016-2023 (USD MILLION) 78
TABLE 46 EUROPE: GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION) 78
TABLE 47 EUROPE: GENE PANELS MARKET, BY DESIGN, 2016-2023 (USD MILLION) 79
TABLE 48 EUROPE: GENE PANELS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 79
TABLE 49 EUROPE: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT,
BY TYPE, 2016-2023 (USD MILLION) 79
TABLE 50 EUROPE: GENE PANELS MARKET, BY END USER, 2016-2023 (USD MILLION) 80
TABLE 51 GERMANY: GENE PANELS MARKET, BY PRODUCT & SERVICE,
2016-2023 (USD MILLION) 80
TABLE 52 GERMANY: GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION) 81
TABLE 53 GERMANY: GENE PANELS MARKET, BY DESIGN, 2016-2023 (USD MILLION) 81
TABLE 54 GERMANY: GENE PANELS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 81
TABLE 55 GERMANY: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT,
BY TYPE, 2016-2023 (USD MILLION) 82
TABLE 56 GERMANY: GENE PANELS MARKET, BY END USER, 2016-2023 (USD MILLION) 82
TABLE 57 UK: GENE PANELS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION) 83
TABLE 58 UK: GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION) 83
TABLE 59 UK: GENE PANELS MARKET, BY DESIGN, 2016-2023 (USD MILLION) 83
TABLE 60 UK: GENE PANELS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 84
TABLE 61 UK: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT,
BY TYPE, 2016-2023 (USD MILLION) 84
TABLE 62 UK: GENE PANELS MARKET, BY END USER, 2016-2023 (USD MILLION) 84
TABLE 63 FRANCE: GENE PANELS MARKET, BY PRODUCT & SERVICE,
2016-2023 (USD MILLION) 85
TABLE 64 FRANCE: GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION) 85
TABLE 65 FRANCE: GENE PANELS MARKET, BY DESIGN, 2016-2023 (USD MILLION) 85
TABLE 66 FRANCE: GENE PANELS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 86
TABLE 67 FRANCE: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT,
BY TYPE, 2016-2023 (USD MILLION) 86
TABLE 68 FRANCE: GENE PANELS MARKET, BY END USER, 2016-2023 (USD MILLION) 86
TABLE 69 ROE: GENE PANELS MARKET, BY PRODUCT & SERVICE,
2016-2023 (USD MILLION) 87
TABLE 70 ROE: GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION) 88
TABLE 71 ROE: GENE PANELS MARKET, BY DESIGN, 2016-2023 (USD MILLION) 88
TABLE 72 ROE: GENE PANELS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 88
TABLE 73 ROE: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT,
BY TYPE, 2016-2023 (USD MILLION) 89
TABLE 74 ROE: GENE PANELS MARKET, BY END USER, 2016-2023 (USD MILLION) 89
TABLE 75 APAC: GENE PANELS MARKET, BY PRODUCT & SERVICE,
2016-2023 (USD MILLION) 91
TABLE 76 APAC: GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION) 92
TABLE 77 APAC: GENE PANELS MARKET, BY DESIGN, 2016-2023 (USD MILLION) 92
TABLE 78 APAC: GENE PANELS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 92
TABLE 79 APAC: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT,
BY TYPE, 2016-2023 (USD MILLION) 93
TABLE 80 APAC: GENE PANELS MARKET, BY END USER, 2016-2023 (USD MILLION) 93
TABLE 81 ROW: GENE PANELS MARKET, BY PRODUCT & SERVICE,
2016-2023 (USD MILLION) 95
TABLE 82 ROW: GENE PANELS MARKET, BY TECHNIQUE, 2016-2023 (USD MILLION) 95
TABLE 83 ROW: GENE PANELS MARKET, BY DESIGN, 2016-2023 (USD MILLION) 96
TABLE 84 ROW: GENE PANELS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 96
TABLE 85 ROW: GENE PANELS MARKET FOR CANCER RISK ASSESSMENT,
BY TYPE, 2016-2023 (USD MILLION) 96
TABLE 86 ROW: GENE PANELS MARKET, BY END USER, 2016-2023 (USD MILLION) 97

 

LIST OF FIGURES

FIGURE 1 GENE PANELS MARKET SEGMENTATION 15
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 KEY DATA FROM SECONDARY SOURCES 19
FIGURE 4 KEY DATA FROM PRIMARY SOURCES 20
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 22
FIGURE 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 23
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 23
FIGURE 8 DATA TRIANGULATION METHODOLOGY 24
FIGURE 9 GENE PANELS MARKET, BY TYPE, 2018 VS. 2023 (USD BILLION) 26
FIGURE 10 GENE PANELS MARKET, BY TECHNIQUE, 2018 VS. 2023 (USD BILLION) 27
FIGURE 11 GENE PANELS MARKET, BY DESIGN, 2018 VS. 2023 (USD BILLION) 27
FIGURE 12 GENE PANELS MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION) 28
FIGURE 13 GENE PANELS MARKET, BY END USER, 2018 VS. 2023 (USD BILLION) 28
FIGURE 14 GLOBAL GENE PANELS MARKET, BY REGION, 2018-2023 29
FIGURE 15 INCREASING PREVALENCE OF CHRONIC DISEASES ONE OF THE MAJOR FACTORS DRIVING THE GROWTH OF THE GLOBAL GENE PANELS MARKET 30
FIGURE 16 TESTING SERVICES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 31
FIGURE 17 RESEARCH AND ACADEMIC INSTITUTES TO CONTINUE TO DOMINATE THE GENE PANELS MARKET IN 2023 31
FIGURE 18 CANCER RISK ASSESSMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE GENE PANELS MARKET IN EUROPE IN 2018 32
FIGURE 19 US TO DOMINATE THE GENE PANELS MARKET IN 2018 33
FIGURE 20 GENE PANELS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 34
FIGURE 21 TEST KITS ACCOUNTED FOR LARGEST SHARE OF THE GENE PANELS MARKET
IN 2018 40
FIGURE 22 AMPLICON-BASED APPROACH TO RESISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 44
FIGURE 23 PREDESIGNED GENE PANELS TO ACCOUNT FOR THE LARGEST SHARE OF THE GENE PANELS MARKET IN 2018 48
FIGURE 24 CANCER RISK ASSESSMENT ACCOUNTED FOR LARGEST SHARE OF THE GENE PANELS MARKET IN 2018 52
FIGURE 25 RESEARCH & ACADEMIC INSTITUTES TO ACCOUNT FOR LARGEST SHARE OF THE GENE PANELS MARKET IN 2018 60
FIGURE 26 NORTH AMERICA: GENE PANELS MARKET SNAPSHOT, 2018 67
FIGURE 27 EUROPE: GENE PANELS MARKET SNAPSHOT, 2018 77
FIGURE 28 ASIA PACIFIC: GENE PANELS MARKET SNAPSHOT, 2018 90
FIGURE 29 REST OF THE WORLD: GENE PANELS MARKET SNAPSHOT, 2018 94
FIGURE 30 KEY DEVELOPMENTS IN THE GENE PANELS MARKET FROM 2015 TO 2018 98
FIGURE 31 MARKET EVOLUTION FRAMEWORK 99
FIGURE 32 GENE PANEL TEST KITS MARKET SHARE ANALYSIS, BY KEY PLAYER (2017) 99
FIGURE 33 ILLUMINA, INC.: COMPANY SNAPSHOT (2017) 103
FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 106
FIGURE 35 AGILENT: COMPANY SNAPSHOT (2017) 109
FIGURE 36 QIAGEN: COMPANY SNAPSHOT (2017) 112
FIGURE 37 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2017) 115
FIGURE 38 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2017) 120

 

ページTOPに戻る

プレスリリース

[プレスリリース原文]

Gene Panels Market worth 2.95 Billion USD by 2023


May 29, 2018

The report "Gene Panel Market by Product & Service, Technique (Amplicon, Hybridization), Design (Predesign, Custom), Application (Cancer, Congenital Disease, Pharmacogenetics) & End User (Hospital, Research Center, Pharmaceutical Companies) - Global Forecast to 2023", The global gene panels market is expected to reach USD 2.95 Billion by 2023 from USD 1.22 Billion in 2018, at a CAGR of 19.2%. The growth of this market is mainly driven by factors such as the increasing prevalence of chronic diseases, growing company initiatives, and growing adoption of gene panels owing to their benefits such as cost-efficiency and simplified the workflow.

The test kits segment is expected to dominate the market in 2018

Based on product & service, the market is segmented into test kits and testing services. In 2018, test kits are expected to account for the largest share of the gene panels market. The growth in this market is mainly driven by the increasing demand for gene panels in research as well as diagnostics to understand the genetic variability of chronic disorders.

Based on technique, the amplicon-based approach segment is expected to dominate the market in 2018

Based on technique, the gene panels market is segmented into the amplicon-based approach and the hybridization-based approach. The amplicon-based approach segment is expected to dominate the market in 2018. This segment is also expected to register the highest growth rate during the forecast period due to the advantages associated with this approach, such as its rapidity, cost-efficiency, and low sample requirement.

The research and academic institutes segment is projected to grow at the highest CAGR during the forecast period.

Based on end user, the market is segmented into research & academic institutes, hospital & diagnostic laboratories, and pharmaceutical & biotechnology companies. The research and academic institutes segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the increasing government funding programs across the globe and the focus of market players on providing efficient gene panels.

North America is expected to dominate the gene panels market in 2018

In 2018, North America is expected to hold the largest share of the gene panels market followed by Europe. The large share of this geographical segment is primarily attributed to the growing research on cancer and inherited rare diseases and the increasing number of NGS-based & clinical applications in the region. Other growth factors include government support for genomics research and the presence of leading NGS providers in this region.

The gene panels market is fragmented, with the presence of several large as well as emerging players. Prominent players in the gene panels market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US). Players in this market are adopting various organic and inorganic strategies, such as product launches & upgradations, agreements, partnerships, joint ventures, collaborations, and acquisition to widen their product portfolios and expand their presence in the market.

 

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る